JPH0115386Y2 - - Google Patents
Info
- Publication number
- JPH0115386Y2 JPH0115386Y2 JP7774485U JP7774485U JPH0115386Y2 JP H0115386 Y2 JPH0115386 Y2 JP H0115386Y2 JP 7774485 U JP7774485 U JP 7774485U JP 7774485 U JP7774485 U JP 7774485U JP H0115386 Y2 JPH0115386 Y2 JP H0115386Y2
- Authority
- JP
- Japan
- Prior art keywords
- cap
- scalp
- polyvinyl alcohol
- aqueous solution
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004761 scalp Anatomy 0.000 claims description 34
- 238000001816 cooling Methods 0.000 claims description 30
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 23
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000007864 aqueous solution Substances 0.000 claims description 17
- 150000002894 organic compounds Chemical class 0.000 claims description 17
- 238000007710 freezing Methods 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 238000007127 saponification reaction Methods 0.000 claims description 4
- 238000010257 thawing Methods 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 description 24
- 210000003128 head Anatomy 0.000 description 16
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229940009456 adriamycin Drugs 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000007872 degassing Methods 0.000 description 3
- 229960004679 doxorubicin Drugs 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000003658 preventing hair loss Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000007798 antifreeze agent Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 240000002836 Ipomoea tricolor Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000004886 head movement Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 238000010094 polymer processing Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Landscapes
- Thermotherapy And Cooling Therapy Devices (AREA)
Description
【考案の詳細な説明】
〈産業上の利用分野〉
本考案は頭皮保冷帽、特に頭皮に密着して変形
が自在な、自在変形型頭皮保冷帽に関する。
〈従来の技術及び問題点〉
冷却用ゲル、保冷用ゲル、保冷用熱媒体、コロ
イド冷媒、保冷用具、保冷用組成物あるいは氷の
いらない氷枕などの名称のもとに、既に各種の冷
却用ゲルが提案され、一部は実用に供されてい
る。これらの保冷用具のうちでも特に頭皮保冷を
目的とするものもあるが、いずれも所定の形状及
び寸度を有しているため、頭皮全域に密着し難
く、また自在に変形できず、多くの人々に適用す
ることができないという欠点があつた。
また、単なる冷水、氷水、粘性液、流動性軟弱
ゲルなどを中空袋内へ充填し、これにより頭皮全
域の保冷を試みる場合、これら充填物が下方へ流
下・偏在することは避けられず、たとえ、バンド
などにより、形状を整えようとしても、所望形状
を保持し難いことは明白である。
〈考案の目的〉
本考案は各種の形状及び寸法の頭皮にも全域に
わたり適合・密着・被覆が可能で、且つ変形自在
で着脱の容易な頭皮保冷帽を提供することを目的
とする。本考案は、特に制癌剤の投与による副作
用として生ずる脱毛症の予防用頭皮保冷帽を提供
する。
〈問題点を解決するための手段〉
本考案によれば、可撓性材料でつくられた中空
ボールを脱気することにより得られる帽子形状の
頭皮保冷帽を構成する前記可撓性材料の二重の帽
子壁内に、けん化度98モル%以上、平均重合度
1000以上のポリビニルアルコールを含み、且つ、
該ポリビニルアルコールの濃度が8wt%を超え、
25wt%以下の水溶液を、任意形状の成型用鋳型
へ注入後、これを−10℃以下の温度に冷却・固
化・成型し、次に、これを解凍する一連の凍結・
解凍操作を反復して累積凍結回数を1〜8とする
ことにより得られる高含水ゴムの小片を複数個、
密封包含させることを特徴とする自在変形型頭皮
保冷帽が提供される。
以下、本考案につき更に詳細に説明する。
本考案に用いるポリビニルアルコールはそのけ
ん化度が、98モル%以上、好ましくは98.5モル%
以上を要する。けん化度80〜88モル%、特に85モ
ル%以下のポリビニルアルコールを用いても、軟
弱なゲルが得られるにすぎす、ゴム状弾性体は生
成しない。また、ポリビニルアルコールの重合度
は1000以上を要する。さもなくば、機械的強度に
劣るゲルが生成する傾向にあり、したがつて重合
度1000〜3300程度のポリビニルアルコール、例え
ば通常市販されている重合度1000〜2600のポリビ
ニルアルコールを用いるのが好ましい。
本考案では、まず、前述のポリビニルアルコー
ルを含む水溶液または懸濁水溶液を調合する。ポ
リビニルアルコールの濃度としては、8wt%を超
え25wt%以下、好ましくは9〜15wt%とするこ
とができる。この濃度を25wt%より高めること
もできるが、水溶液の粘度増加が激しく、操作に
不便をきたす傾向があるうえ、含水率が75wt%
より低下し、保冷持続能の点でも劣る傾向にあ
る。また、この濃度を8wt%より低下させると、
保冷用としては軟弱にすぎ、ゲル成型体の形くず
れ崩壊を伴う傾向にある。
本考案により得られる頭皮保冷帽を、特に氷点
下の低温に予冷することなく、例えば0〜10℃程
度に予冷して供する用途には、上述のとおりポリ
ビニルアルコール水溶液を調製すれば、十分初期
の目的を達することができるが、頭皮保冷帽を0
℃以下に予冷後、使用に供する場合には、更に前
記ポリビニルアルコール水溶液へ水溶性有機化合
物を溶解させてゲルの氷結硬化点を0℃以下、例
えば−15℃〜−20℃へ降下させることができる。
かような場合には、ゲルの形成に先立ち、上記
ポリビニルアルコール水溶液に凍結防止剤(氷結
点降下剤)としての水溶性有機化合物を溶解させ
る。水溶性有機化合物としてはメチルアルコー
ル、エチルアルコール、イソプロピルアルコール
などの水溶性1価アルコール及びその誘導体、エ
チレングリコール、プロピレングリコール、1,
3−プロピレングリコール、グリセリン、2−メ
チル−2,4−ペンタンジオールなどの水溶性多
価アルコール、アセトン、ジメチルスルホキシ
ド、メチルスルホン酸、エチルスルホン酸、ジメ
チルアミン、メチルアミン、ギ酸などの他の水溶
性有機化合物を挙げることができる。この他、単
糖類(エリトリトール、アラビノース、キシロー
ス、キシリトール、グルコース、グルシトール
(ソルビトール、ソルビツト)、グルコン酸、グル
クロン酸、グルカル酸、ガラクツロン酸、フルク
トース、グルコサミン)、二糖類(スクロース、
セロビオース、ラクトース)、三糖類(ラフイノ
ース)、水溶性多糖類(アガロース、アミロース、
アルギン酸ナトリウム、グリコゲン、コンドロイ
チン、コンドロイチン硫酸、デキストラン、ペク
チン酸、アルギン酸プロピレングリコールエステ
ル、トラガント・ガム、プルラン、コンドロイチ
ン硫酸ナトリウム)を挙げることができる。これ
らの水溶性有機化合物のうち、特に無臭で、揮発
性のきわめて乏しい利点および比較的少量の置換
により氷結点降下の目的を達成しうること、更に
は得られるゲルの機械的強度への寄与等を考慮し
て、エチレングリコール、プロピレングリコール
さらにはグリセリン、D−ソルビトールなどが好
ましい。
前述の水溶性有機化合物の共存濃度としては、
5〜40wt%、好ましくは10〜35wt%とする。こ
の共存濃度を10wt%より低くする場合、ゲルの
氷結・硬化点を−10℃以下に低下させ難い。ま
た、共存濃度が40wt%より高いと、氷結点を不
必要なまでに低下させる場合があるほか、氷結・
硬化点をかえつて高める結果を招く場合もあり、
いずれにしてもいたずらに経済的負担を増大させ
る。水溶性有機化合物を共存させることにより、
ゲルの硬化温度は−20℃以下に低下し、通常の家
庭用冷蔵庫(冷凍庫)の氷室(−10〜−20℃)で
は通常、硬化せず、柔軟性および生体組織類似の
感触を保持することができる。
上記の、ポリビニルアルコールおよび凍結防止
剤としての水溶性有機化合物の双方を含む水溶液
を調合する場合には、水中へポリビニルアルコー
ルと該水溶性有機化合物とを添加・溶解・懸濁さ
せる方式のほか、あらかじめ水中へポリビニルア
ルコールを溶解し、しかる後、これを該水溶性有
機化合物(またはその水溶液)と混合する方式、
あるいは該水溶性有機化合物(またはその水溶
液)へポリビニルアルコール水溶液またはポリビ
ニルアルコール粉末を添加・溶解・懸濁させる方
式などを採ることができ、いずれの方式において
も、最終的に、ポリビニルアルコール濃度が8wt
%を超え、25wt%以下、該水溶性有機化合物濃
度5〜40wt%に調整する。
本考案においては、上記ポリビニルアルコール
又はこれに更に水溶性有機化合物を含む水溶液ま
たは懸濁水溶液を、所望の成型用鋳型へ注入し、
冷却・成型する。
この場合、冷却剤としては、例えば、食塩−氷
(23:77)(−21℃)、塩化カルシウム−氷(30:
70)(−55℃)などの寒剤、あるいは、ドライア
イス−メチルアルコール(−72℃)、液体窒素
(−196℃)などを用い、−10℃以下の温度に冷却
する。また、液体ヘリウムを用いれば−269℃ま
で冷却できるが、不経済であるうえ、ゲルの品位
に利点はなく、実用上はフレオン冷凍機を用い、
たとえば−20〜−80℃に冷却するのが良い。家庭
用冷蔵庫(冷凍庫)製氷室(−10〜−20℃)へ収
めて冷却することも、もち論差し支えない。
冷却が不十分であると、得られるゲルの機械的
強度が劣るため、本考案に好ましくない。
したがつて、本考案においては、ポリビニルア
ルコール又は更にこれに水溶性有機化合物を含む
水溶液を、−10℃以下、好ましくは−20℃以下に
到達させる。
本考案においては前述の冷却処理後、これを解
凍する一連の解凍操作を反復し、累積凍結回数を
1〜8とすることにより、本考案に供しうる高含
水ゲル(ゴム)を得ることができる。累積凍結回
数を高めるとともに、得られる高含水ゴムの硬度
も向上するが、累積凍結回数8以降は、その効果
がほぼ消失すること(南部昌生、高分子加工、
32,523(1983))から、上述の1〜8、好ましく
は2〜6が経済的である。
本考案では上述のようにして得た高含水ゲルを
小片に形成するが、ポリビニルアルコール又はこ
れに更に水溶性有機化合物を含む水溶液を小片成
型用鋳型へ注入して、直接複数個の高含水ゲルの
小片を成型してもよい。また、直接高含水ゲルの
小片を成型しない場合には、任意形状として得ら
れた高含水ゲルを切断して複数個の小片とするこ
ともできる。高含水ゲルの小片の形状は特に限定
されるものではなく、立方体、直方体、円柱状、
球状などいずれの形状でもよく、またその寸度も
臨界的なものではなく、後述するように上記帽子
壁内に包含させた際、外表面から指圧を加えるこ
とにより変形自在であればよい。大きさとしては
通常、一辺若しくは直径などの寸度が2mm〜3cm
であるのが好ましい。
〈実施例〉
本考案の頭皮保冷帽の一実施態様を添付図面を
参照して説明する。第1図には上述のようにして
得られた高含水ゲル(高含水ゴム)の小片を複数
個、可撓性材料で作られた中空ボール2(球状ま
たは楕円球形)内に収める。
小片の充填量としては、要求される保冷能の観
点から、0.3Kg以上が望ましいが、保冷帽装着時
の患者への負担を考慮して、3Kg以下が好まし
く、0.3〜3Kg、特に好ましくは0.35〜2Kgとす
ることにより、脱毛防止の目的を十分達成するこ
とができる。この小片を収める可撓性中空ボール
2としては、ポリ塩化ビニル、ポリエチレン、ポ
リプロピレンなどのプラスチツクフイルム製中空
ボールまたは肉薄のゴムボールが、頭皮への感
触、密封性などの点から好ましく、例えばポリ塩
化ビニル製ビーチボール、ポリプロピレン・ナイ
ロン重積層フイルム製風船、飴ゴム製肉薄ゴムボ
ールなどが至便であるほか、前記軟質フイルムに
より製作されたラグビーボール、アメリカンフツ
トボール用ボール、飛行船、UFO(空飛ぶ円盤)
などの模型玩具も、本考案の球形または楕円形中
空ボールの機能を具えるかぎり、利用することが
できる。これらの中空ボールへ前記含水ゲル(含
水ゴム)の小片1を収めるには、必要に応じ、中
空ボール2の壁面に、小片投入口3をもうけるこ
とができるほか、あらかじめ、中空ボールの制作
時に、小片投入口を付設することもできる。本考
案においては、この投入口3から、所定量の含水
ゴム小片を投入後、中空ボール内の不必要な空気
を放出する。即ち、頭部被覆のためのボール壁面
陥没部(くぼみ)を得るにあたり、中空ボール内
を脱気する必要がある。脱気が不十分で多量の空
気が残存すると、小片1が下方へ流下し易く、頭
皮全域の均一保冷に支障をきたす。従つて、上記
の空気放出はきわめて重要な意味を持つが、必ず
しも完全に全ての空気を排除する必要はなく、ボ
ール壁面を圧迫することにより、大部分の空気を
放出すれば良い。しかる後、ボール壁面の開口部
3を全て閉鎖・密封する。この封鎖に際し、開口
部を熱融着させることができるほか、開口部を紐
により縛るか、密栓を施すか、あるいは接着剤に
より貼着することもできる。第2図には脱気して
得られた本考案の頭皮保冷帽10が示される。図
示の例では密封栓4により開口部3を封鎖したと
ころを示す。
上述の空気放出・ボール壁封鎖処置により、中
空ボールは必然的に三日月形(舟形、ボート形)
を呈し、本考案の保冷帽10が得られる。
高含水ゴム充填量は、前述のとおり、0.3〜3
Kgであるが、充填層厚みを3cm以上とすること
は、保冷持続時間を、しばしば不必要なまでに延
長させるうえ、患者に余分の重量負担を強いるこ
とを意味するので、充填層厚みが0.6〜2.5cm、好
ましくは0.8〜2cmに収まるよう、中空ボールの
寸度に応じ、充填量を選定するのが良い。好まし
い充填量の例としては、直径32cmの中空ボールに
1.2〜2Kg(充填層厚み0.8〜2cm)、直径16cmの
中空ボールに0.3〜0.6Kg(充填層厚み0.8〜2cm)
などである。
本考案の保冷帽10の装着にあたつては、保冷
帽の陥没部(内側)5を頭部6にあて、保冷帽の
外表面から指圧を加えて、充填層の一部を適宜移
動させ、頭髪の存在する全域が充填層によりほぼ
均一に被覆されるよう整えるとともに、患者各自
の頭部形状に合わせつつ、保冷帽壁の余分の部分
を、指先を以つてつまむことにより、保冷帽の寸
度を適宜短縮させ、あるいはまた、頭囲を超える
余剰部分に折返し7を付し、保冷帽が頭部全域に
密着するよう、保冷帽の形状を最終的に整える。
本考案においては、この保冷帽を装着後、頭皮
への密着を持続させ、しかも、患者が首を振るな
どの頭部動作の際にも、この密着状況を保持する
ことを目的として、保冷帽裾の周囲に、弾性帯8
(バンド、平面フアスナー、弾性包帯)を巻き付
け、固定するのが好ましい(第4図参照)。
中空ボールの寸度に関しては、頭皮全域を密
着・被覆する観点から、下記事項に配慮する。即
ち、乳幼児および児童の頭形は球形に近く、従つ
て、その頭囲相当の半球形保冷帽により、頭皮の
ほぼ全域を被覆できる。更に眉毛、項部
(nuchal region)、鬢(side−whiskers)などを
も保冷するには、頭囲寸法を超える寸度の保冷帽
を用い、しかもその頭囲寸度を超える余分のボー
ル壁部分を折りたたみ、しかる後、保冷帽の裾周
囲に弾性帯8(平面フアスナー、マジツクベル
ト)または弾性包帯を巻き、保冷帽10を頭囲に
沿つて密着させれば良い。成人においては、脳頭
蓋(眼から上方の部分)は子供と大差無いもの
の、顔面及び頭高の長いことを考慮し、縦長のボ
ール(楕円球)を用いる保冷帽が特に望ましい
が、便宜上、頭囲寸度を超える球形ボールを用
い、ボール壁の余分の部分をつまむか、折りたた
み(第3図)、上述のとおり、保冷帽の裾部に弾
性帯8(ベルト)を巻きつけてボール径を短縮
し、縦長(つぼ型)に整形して用いることもでき
る。従つて、中空ボールの寸度としては、頭髪全
域を被覆する観点から、直径15〜32cmの球形また
は短径12〜32cm未満、長径15〜32cmが望ましく、
特に乳幼児(頭囲33.5〜51cm)には直径15〜24cm
の球形、または短径12〜24cm未満、長径15〜24cm
の楕円球形、また児童(頭囲50〜52cm)には、直
径17〜25cmの球形、または短径14〜25cm未満、長
径17〜25cmの楕円球形、更に成人には、直径19〜
32cmの球形、または短径17〜32cm未満、直径19〜
32cmの楕円球形が好適である。いずれの場合に
も、これらにより、頭頂部は勿論のこと、後頭
部、側頭部(temporal region)、眉毛などを全
て被覆できるほか、更には、鬢(sideburn,side
−whiskers)、項部(nuchal region)をも被覆
することができる。
〈考案の効果〉
本考案においては、頭皮全域を高含水ゴム小片
1の充填物により被覆できるうえ、指圧を加えて
充填物を適宜移動させることにより、患者それぞ
れの頭形に応じ、任意形状に変形させることが容
易で、しかも、指圧解除後、所望形状がそのまま
保持される。
本考案の頭皮保冷帽は、癌患者に制癌剤を投与
することにより生ずる脱毛阻止に好適で、特に抗
生物質として多用されるアドリアマイシン
(Adriamycin)即ち14−ヒドロキシダウノルビ
シン(ドキソルビシン)(14−hydroxy
daunorubicin,doxorubicin)などの副作用とし
ての激しい脱毛の予防・阻止に多大の利用価値を
発揮する。
本考案の保冷帽の通常使用法としては、冷蔵庫
(3〜10℃)に1晩収めた後、アドリアマイシン
の注射に先立ち、前記のとおり着用し、頭髪全域
に充填層を密着・適合させたうえ、アドリアマイ
シンを注射する。
充填層の厚みが例えば13mmの場合、頭皮温度
は、装着後30minにわたり25℃以下に保持され、
同じく、60minにわたり30℃以下に保持される
が、通常、注射後、15minにわたり、頭皮温度を
25〜30℃に冷却することにより、脱毛防止の目的
が十分達成される。
アドリアマイシンの注射所要時間は通常約
5min以内であるが、病院によつては、1〜2hを
要して点滴投与する例もある。後者の例に対して
は、本考案の保冷帽の充填層厚みを2.5〜3.5cmへ
増すことにより、保冷持続時間を延長させること
もできるが、充填物(重量)による患者への負担
を考慮して、前述のとおり、充填層厚みを0.8〜
2cmとし、点滴期間中、30〜60min毎に、あらか
じめ予冷した保冷帽と更新するのが良い。
アドリアマイシンの投与量としては、30〜50mg
m-2(体表面積1m2あたり投与量)が通例である
が、更に多量、例えば60〜80mgm-2(体重1Kgあ
たり、成人;1.6〜2.3mg,13〜19歳;1.6〜2.5mg,
7〜12歳;2〜3.5mg,0〜6歳;2.5〜11mg)が
投与される例もある。このような多量投与の場合
は、特に頭皮を深冷することを望む声もある(J.
G.Dean,S.E.Salmon etal.,N.Eng.J.Med.,
301,253(1977))。この要望に応えるには、前述
の水溶性有機化合物を併用する処法により得た高
含水ゴムを、厚さ2〜3cmに達するよう充填し、
しかも、この保冷帽を冷凍庫(製氷室、−20℃)
に収めて予冷後装着する方式を採り、着用後40〜
50minにわたり、頭皮温度を20℃以下に保持する
ことができる。 [Detailed Description of the Invention] <Industrial Application Field> The present invention relates to a scalp cooling cap, and particularly to a freely deformable scalp cooling cap that can be freely deformed while closely contacting the scalp. <Prior art and problems> Various cooling gels have already been developed under the names of cooling gels, cold preservation gels, cold heat transfer media, colloidal refrigerants, cold preservation tools, cold preservation compositions, and ice pillows that do not require ice. have been proposed, and some have been put into practical use. Among these cooling devices, some are specifically designed to keep the scalp cool, but because they all have a predetermined shape and size, they are difficult to fit tightly to the entire scalp, and cannot be deformed freely. The drawback was that it could not be applied to people. Furthermore, when simply cold water, ice water, viscous liquid, fluid soft gel, etc. are filled into a hollow bag in an attempt to keep the entire scalp cool, it is unavoidable that these fillers flow downward and become unevenly distributed. Even if an attempt is made to adjust the shape with a band or the like, it is obvious that it is difficult to maintain the desired shape. <Purpose of the invention> The object of the invention is to provide a scalp cooling cap that can fit, adhere to, and cover the entire scalp of various shapes and sizes, is deformable, and is easy to put on and take off. The present invention particularly provides a scalp cooling cap for preventing alopecia that occurs as a side effect of administration of anticancer drugs. <Means for Solving the Problems> According to the present invention, two of the flexible materials constituting a cap-shaped scalp cooling cap obtained by deaerating a hollow ball made of a flexible material. Inside the heavy cap wall, saponification degree is 98 mol% or more, average polymerization degree
Contains polyvinyl alcohol of 1000 or more, and
The concentration of the polyvinyl alcohol exceeds 8wt%,
After injecting an aqueous solution of 25wt% or less into a molding mold of any shape, it is cooled to a temperature of -10°C or less, solidified, and molded, and then thawed.
A plurality of small pieces of high water content rubber obtained by repeating the thawing operation to make the cumulative number of freezing times 1 to 8,
A freely deformable scalp cooling cap is provided which is characterized by a hermetically sealed enclosure. The present invention will be explained in more detail below. The polyvinyl alcohol used in the present invention has a saponification degree of 98 mol% or more, preferably 98.5 mol%.
The above is required. Even if polyvinyl alcohol with a saponification degree of 80 to 88 mol%, particularly 85 mol% or less, is used, only a soft gel is obtained, but no rubber-like elastic body is produced. Further, the degree of polymerization of polyvinyl alcohol is required to be 1000 or more. Otherwise, a gel with poor mechanical strength tends to be produced. Therefore, it is preferable to use polyvinyl alcohol with a degree of polymerization of about 1000 to 3300, such as a commercially available polyvinyl alcohol with a degree of polymerization of 1000 to 2600. In the present invention, first, an aqueous solution or suspension aqueous solution containing the aforementioned polyvinyl alcohol is prepared. The concentration of polyvinyl alcohol can be more than 8 wt% and 25 wt% or less, preferably 9 to 15 wt%. Although this concentration can be increased above 25wt%, the viscosity of the aqueous solution increases sharply, which tends to cause inconvenience in operation, and the water content is 75wt%.
It also tends to be inferior in terms of cold retention ability. Also, if this concentration is lowered below 8wt%,
It is too soft for cold storage, and the gel molded product tends to lose its shape and collapse. In order to use the scalp cooling cap obtained by the present invention without pre-cooling it to a low temperature below freezing point, for example, to about 0 to 10 degrees Celsius, it is sufficient to prepare the polyvinyl alcohol aqueous solution as described above. can be reached, but the scalp cooling cap is 0.
After pre-cooling to below 0°C, when ready for use, it is possible to further dissolve a water-soluble organic compound in the polyvinyl alcohol aqueous solution to lower the freezing hardening point of the gel to below 0°C, for example, from -15°C to -20°C. can. In such a case, a water-soluble organic compound as an antifreeze agent (freezing point depressant) is dissolved in the polyvinyl alcohol aqueous solution prior to gel formation. Water-soluble organic compounds include water-soluble monohydric alcohols such as methyl alcohol, ethyl alcohol, and isopropyl alcohol and their derivatives, ethylene glycol, propylene glycol,
Water-soluble polyhydric alcohols such as 3-propylene glycol, glycerin, 2-methyl-2,4-pentanediol, other water-soluble polyhydric alcohols such as acetone, dimethylsulfoxide, methylsulfonic acid, ethylsulfonic acid, dimethylamine, methylamine, formic acid, etc. Examples include organic compounds. In addition, monosaccharides (erythritol, arabinose, xylose, xylitol, glucose, glucitol (sorbitol, sorbitol), gluconic acid, glucuronic acid, glucaric acid, galacturonic acid, fructose, glucosamine), disaccharides (sucrose,
cellobiose, lactose), trisaccharides (raffinose), water-soluble polysaccharides (agarose, amylose,
Sodium alginate, glycogen, chondroitin, chondroitin sulfate, dextran, pectic acid, propylene glycol alginate, gum tragacanth, pullulan, sodium chondroitin sulfate). Among these water-soluble organic compounds, the advantages are that they are odorless and have extremely low volatility, that they can achieve the objective of lowering the freezing point with a relatively small amount of substitution, and that they contribute to the mechanical strength of the resulting gel. In consideration of this, ethylene glycol, propylene glycol, glycerin, D-sorbitol, etc. are preferable. The coexisting concentration of the water-soluble organic compounds mentioned above is:
The content is 5 to 40 wt%, preferably 10 to 35 wt%. When this coexisting concentration is lower than 10 wt%, it is difficult to lower the freezing/hardening point of the gel to -10°C or lower. Additionally, if the coexisting concentration is higher than 40wt%, the freezing point may be lowered unnecessarily, and freezing and
In some cases, this may actually increase the hardening point.
In either case, it unnecessarily increases the economic burden. By coexisting water-soluble organic compounds,
The curing temperature of the gel drops to -20°C or lower, and it does not harden in the ice chamber (-10 to -20°C) of a regular household refrigerator (freezer), maintaining flexibility and a feel similar to living tissue. I can do it. When preparing an aqueous solution containing both polyvinyl alcohol and a water-soluble organic compound as an antifreeze agent, as described above, in addition to adding, dissolving, or suspending polyvinyl alcohol and the water-soluble organic compound in water, A method in which polyvinyl alcohol is dissolved in water in advance and then mixed with the water-soluble organic compound (or its aqueous solution);
Alternatively, a method can be adopted in which a polyvinyl alcohol aqueous solution or polyvinyl alcohol powder is added, dissolved, or suspended in the water-soluble organic compound (or its aqueous solution). In either method, the final polyvinyl alcohol concentration is 8 wt.
% and below 25 wt%, and the concentration of the water-soluble organic compound is adjusted to 5 to 40 wt%. In the present invention, an aqueous solution or suspension aqueous solution containing the polyvinyl alcohol or a water-soluble organic compound therein is injected into a desired mold,
Cool and mold. In this case, the coolant may be, for example, salt-ice (23:77) (-21°C), calcium chloride-ice (30:77) (-21°C),
70) (-55°C), dry ice-methyl alcohol (-72°C), liquid nitrogen (-196°C), etc., to a temperature below -10°C. In addition, liquid helium can be used to cool down to -269°C, but it is uneconomical and has no advantage in gel quality, so in practice a Freon refrigerator is used.
For example, it is best to cool it to -20 to -80°C. There is no harm in cooling it by storing it in a home refrigerator (freezer) or icemaker (-10 to -20℃). Insufficient cooling is not preferred for the present invention because the resulting gel has poor mechanical strength. Therefore, in the present invention, polyvinyl alcohol or an aqueous solution containing a water-soluble organic compound therein is heated to -10°C or lower, preferably -20°C or lower. In the present invention, after the above-mentioned cooling treatment, a series of thawing operations are repeated to thaw the product, and the cumulative number of times of freezing is 1 to 8, thereby obtaining a high water content gel (rubber) that can be used in the present invention. . As the cumulative number of freezing times increases, the hardness of the obtained high water content rubber also improves, but after 8 cumulative freezing times, this effect almost disappears (Masao Nanbu, Polymer Processing,
32, 523 (1983)), the above-mentioned 1 to 8, preferably 2 to 6, are economical. In the present invention, the high water content gel obtained as described above is formed into small pieces. Polyvinyl alcohol or an aqueous solution containing a water-soluble organic compound is injected into a mold for forming small pieces, and multiple pieces of high water content gel are directly formed. You may also mold small pieces. In addition, if small pieces of high hydrous gel are not directly molded, the high hydrous gel obtained in an arbitrary shape can be cut into a plurality of small pieces. The shape of the small pieces of high water content gel is not particularly limited, and may be cubic, rectangular parallelepiped, cylindrical, etc.
It may have any shape such as a spherical shape, and its dimensions are not critical as long as it can be deformed by applying finger pressure from the outer surface when it is included in the cap wall as described later. The size is usually 2 mm to 3 cm on a side or in diameter.
It is preferable that <Example> An embodiment of the scalp cooling cap of the present invention will be described with reference to the accompanying drawings. In FIG. 1, a plurality of small pieces of high water content gel (high water content rubber) obtained as described above are placed in a hollow ball 2 (spherical or ellipsoidal) made of a flexible material. The amount of small pieces filled is preferably 0.3 kg or more from the viewpoint of the required cold storage capacity, but in consideration of the burden on the patient when wearing a cold cap, it is preferably 3 kg or less, 0.3 to 3 kg, particularly preferably 0.35 kg. By setting the weight to 2 kg, the purpose of preventing hair loss can be sufficiently achieved. As the flexible hollow ball 2 for storing this small piece, a hollow ball made of plastic film such as polyvinyl chloride, polyethylene, or polypropylene or a thin rubber ball is preferable from the viewpoint of feeling on the scalp and sealing property. Vinyl beach balls, balloons made of polypropylene/nylon laminated film, thin rubber balls made of candy rubber, etc. are most convenient, as well as rugby balls, American football balls, airships, and UFOs (flying saucers) made of the above-mentioned soft films. )
Model toys such as the above can also be used as long as they have the function of the spherical or oval hollow ball of the present invention. In order to store the small pieces 1 of the water-containing gel (water-containing rubber) into these hollow balls, a small piece inlet 3 can be provided on the wall surface of the hollow ball 2 if necessary, and in advance, when producing the hollow balls, A small piece inlet may also be provided. In the present invention, after a predetermined amount of water-containing rubber pieces are input through the input port 3, unnecessary air inside the hollow ball is released. That is, in order to obtain a depression on the wall of the ball for covering the head, it is necessary to evacuate the inside of the hollow ball. If a large amount of air remains due to insufficient degassing, the small pieces 1 tend to flow downward, which impedes uniform cooling of the entire scalp. Therefore, although the air release described above is extremely important, it is not necessary to completely eliminate all the air; it is sufficient to release most of the air by compressing the ball wall surface. After that, all the openings 3 on the wall of the ball are closed and sealed. In order to seal the opening, the opening can be heat-sealed, or the opening can be tied with a string, sealed with a seal, or adhered with an adhesive. FIG. 2 shows the scalp cooling cap 10 of the present invention obtained by degassing. In the illustrated example, the opening 3 is sealed with a sealing plug 4. Due to the above-mentioned air release and ball wall sealing measures, the hollow ball inevitably has a crescent shape (boat shape, boat shape).
The cold cap 10 of the present invention is obtained. As mentioned above, the high water content rubber filling amount is 0.3 to 3
However, setting the filling layer thickness to 3 cm or more means that the duration of cold storage is often extended unnecessarily and the patient is forced to bear extra weight, so the filling layer thickness is 0.6 kg. It is best to select the filling amount according to the size of the hollow ball so that the filling amount is ~2.5 cm, preferably 0.8 ~ 2 cm. An example of a preferred filling amount is for a hollow bowl with a diameter of 32 cm.
1.2-2Kg (filling layer thickness 0.8-2cm), 0.3-0.6Kg (filling layer thickness 0.8-2cm) in a hollow ball with a diameter of 16cm
etc. When wearing the ice pack 10 of the present invention, place the recessed part (inside) 5 of the ice pack on the head 6 and apply finger pressure from the outer surface of the ice pack to move a part of the filling layer as appropriate. The filling layer is arranged so that the entire area where hair exists is almost uniformly covered, and the extra part of the ice cap wall is pinched with the fingertips to fit the shape of each patient's head. The shape of the ice pack is finally adjusted so that the size of the ice pack is shortened appropriately, or a fold 7 is added to the excess portion exceeding the head circumference so that the ice cap fits tightly over the entire head area. In this invention, the cooling cap is designed to maintain close contact with the scalp after the patient puts it on, and to maintain this close contact even when the patient makes head movements such as shaking his head. Elastic band 8 around the hem
It is preferable to wrap and secure it with a band (band, flat fastener, elastic bandage) (see Figure 4). Regarding the dimensions of the hollow ball, consider the following points from the viewpoint of adhering and covering the entire scalp. That is, the head shapes of infants and children are close to spherical, and therefore, a hemispherical ice pack corresponding to the head circumference can cover almost the entire scalp. Furthermore, in order to keep eyebrows, nuchal region, side-whiskers, etc. cool, a cooler cap with a size that exceeds the head circumference is used, and an extra ball wall portion that exceeds the head circumference is used. After that, an elastic band 8 (plane fastener, magic belt) or an elastic bandage is wrapped around the hem of the ice-packed cap, and the ice-packed cap 10 is tightly fitted along the circumference of the head. In adults, the brain cranium (the part above the eyes) is not much different from that of children, but considering the long face and head height, it is especially desirable to wear a cold cap with a vertically long ball (ellipsoid). Using a spherical ball that exceeds the enclosing dimensions, pinch or fold the excess wall of the ball (Figure 3), and as described above, wrap the elastic band 8 (belt) around the hem of the ice pack to reduce the diameter of the ball. It can also be shortened and shaped into a vertically long (vase-shaped) shape. Therefore, the dimensions of the hollow ball are preferably spherical with a diameter of 15 to 32 cm, or a shorter axis of less than 12 to 32 cm and a longer axis of 15 to 32 cm, from the viewpoint of covering the entire hair.
Especially for infants (head circumference 33.5-51cm) with a diameter of 15-24cm.
Spherical shape, or short axis less than 12-24cm, major axis 15-24cm
For children (head circumference 50-52cm), a spherical shape with a diameter of 17-25cm, or an oval-spherical shape with a minor axis of less than 14-25cm and a major axis of 17-25cm, and for adults, a diameter of 19-25cm.
32cm spherical, or short axis 17~32cm, diameter 19~
A 32 cm oval spherical shape is preferred. In either case, these can cover not only the top of the head, but also the occiput, temporal region, eyebrows, etc., as well as the sideburn and sideburns.
-whiskers), nuchal region can also be covered. <Effects of the invention> In the present invention, the entire scalp can be covered with a filler made of small pieces of highly water-containing rubber 1, and by applying finger pressure and moving the filler appropriately, it can be formed into any shape according to the head shape of each patient. It is easy to deform, and moreover, the desired shape is maintained as it is after the finger pressure is released. The scalp cooling cap of the present invention is suitable for preventing hair loss caused by administering anticancer drugs to cancer patients, and is particularly suitable for Adriamycin, which is frequently used as an antibiotic, or 14-hydroxy daunorubicin (doxorubicin).
It has great utility in preventing and inhibiting severe hair loss as a side effect of drugs such as daunorubicin and doxorubicin. The usual method of using the ice pack of this invention is to store it in the refrigerator (3 to 10℃) overnight, then wear it as described above before injecting adriamycin, and then apply the filling layer to the entire hair area, and then put it on as described above. , inject adriamycin. For example, if the thickness of the filling layer is 13 mm, the scalp temperature will be maintained at 25 degrees Celsius or less for 30 minutes after installation.
Similarly, the scalp temperature is maintained below 30°C for 60 min, but usually the scalp temperature is kept below 30°C for 15 min after injection.
By cooling to 25-30°C, the purpose of preventing hair loss is fully achieved. The injection time for Adriamycin is usually approx.
Although the administration time is within 5 minutes, some hospitals require 1 to 2 hours for intravenous administration. For the latter case, it is possible to extend the duration of cold retention by increasing the thickness of the filling layer of the cooling cap of the present invention to 2.5 to 3.5 cm, but the burden on the patient due to the filling (weight) can be taken into consideration. As mentioned above, the filling layer thickness is set to 0.8~
It is best to use a pre-chilled ice cap and replace it every 30 to 60 minutes during the infusion period. Adriamycin dosage is 30-50mg
m -2 (dose per 1 m 2 of body surface area), but higher doses, for example 60 to 80 mg m -2 (per kg of body weight, adults: 1.6 to 2.3 mg, 13 to 19 years old: 1.6 to 2.5 mg,
In some cases, 7-12 years old: 2-3.5 mg; 0-6 years old: 2.5-11 mg). When administering such a large amount, some people recommend that the scalp be deeply cooled (J.
G.Dean, SESalmon etal., N.Eng.J.Med.,
301, 253 (1977)). In order to meet this demand, high water content rubber obtained by the above-mentioned treatment method that uses a water-soluble organic compound in combination is filled to a thickness of 2 to 3 cm.
What's more, you can store this ice pack in the freezer (ice maker, -20℃).
The method is to pre-cool the product and then put it on.
Scalp temperature can be maintained below 20℃ for 50min.
第1図は本考案の頭皮保冷帽をつくるため中空
ボール内に高含水ゲルの小片を収めたところを示
す一部破断斜視図、第2図は脱気して得られた本
考案の頭皮保冷帽を示す断面図、第3図は頭皮保
冷帽を装着したところを示す略図、第4図は平面
フアスナーを巻いたところを示す略図である。
図中、1は高含水ゲルの小片、2は中空ボー
ル、3は小片投入口、10は頭皮保冷帽である。
Figure 1 is a partially cutaway perspective view showing a small piece of high water content gel placed inside a hollow ball to make the scalp cooling cap of the present invention, and Figure 2 is a scalp cooling cap of the present invention obtained by degassing. A sectional view showing the cap, FIG. 3 is a schematic view showing the scalp cooling cap being worn, and FIG. 4 is a schematic view showing the flat fastener being wrapped. In the figure, 1 is a small piece of high water content gel, 2 is a hollow ball, 3 is a small piece inlet, and 10 is a scalp cooling cap.
Claims (1)
ることにより得られる帽子形状の頭皮保冷帽を
構成する前記可撓性材料の二重の帽子壁内に、
けん化度98モル%以上、平均重合度1000以上の
ポリビニルアルコールを含み、且つ、該ポリビ
ニルアルコールの濃度が8wt%を超え、25wt%
以下の水溶液を、任意形状の成型用鋳型へ注入
後、これを−10℃以下の温度に冷却・固化・成
型し、次に、これを解凍する一連の凍結・解凍
操作を反復して累積凍結回数を1〜8とするこ
とにより得られる高含水ゴムの小片を複数個、
密封包含させることを特徴とする自在変形型頭
皮保冷帽。 2 前記水溶液が、濃度5〜40wt%の水溶性有
機化合物を含むことを特徴とする実用新案登録
請求の範囲第1項記載の自在変形型頭皮保冷
帽。[Claims for Utility Model Registration] 1. Within the double cap wall of the flexible material constituting a cap-shaped scalp cooling cap obtained by deaerating a hollow ball made of a flexible material,
Contains polyvinyl alcohol with a saponification degree of 98 mol% or more and an average polymerization degree of 1000 or more, and the concentration of the polyvinyl alcohol exceeds 8 wt% and 25 wt%
After injecting the following aqueous solution into a mold for any shape, it is cooled to a temperature below -10℃, solidified, and molded, and then thawed. A series of freezing and thawing operations is repeated to cumulatively freeze the solution. A plurality of small pieces of high water content rubber obtained by making the number of times 1 to 8,
A freely deformable scalp cooling cap characterized by a hermetically sealed structure. 2. The freely deformable scalp cooling cap according to claim 1, wherein the aqueous solution contains a water-soluble organic compound at a concentration of 5 to 40 wt%.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7774485U JPH0115386Y2 (en) | 1985-05-27 | 1985-05-27 | |
DE8686107207T DE3678212D1 (en) | 1985-05-27 | 1986-05-27 | DEFORMABLE HOOD COOLING HOOD. |
EP86107207A EP0208113B1 (en) | 1985-05-27 | 1986-05-27 | Deformable cap for scalp cooling |
US07/158,122 US5163425A (en) | 1985-05-27 | 1988-02-16 | Deformable cap for scalp cooling |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7774485U JPH0115386Y2 (en) | 1985-05-27 | 1985-05-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61194511U JPS61194511U (en) | 1986-12-04 |
JPH0115386Y2 true JPH0115386Y2 (en) | 1989-05-09 |
Family
ID=30621093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7774485U Expired JPH0115386Y2 (en) | 1985-05-27 | 1985-05-27 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0115386Y2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6249308B2 (en) * | 2015-06-09 | 2017-12-20 | 英君 梁川 | Body cooling heater |
-
1985
- 1985-05-27 JP JP7774485U patent/JPH0115386Y2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS61194511U (en) | 1986-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5163425A (en) | Deformable cap for scalp cooling | |
JPH0444603Y2 (en) | ||
JPS5930881A (en) | Manufacture of low-temperature insulating gel | |
US20120165910A1 (en) | Cold compress for therapeutic cooling | |
US20080119916A1 (en) | Cold Compress for Therapeutic Cooling | |
JPH08508918A (en) | Compresses for cold and / or warm treatment of wounds | |
US20070105977A1 (en) | Kneadable Hand Putty as a Delivery System for Skin Conditioning and/or Thermal Therapy Agents | |
US20150272775A1 (en) | Multi-phase mixed material therapy pack | |
JPH0115386Y2 (en) | ||
JPH0115385Y2 (en) | ||
CN207679609U (en) | Craniocerebral disease ice cap | |
CN203280566U (en) | Anti-explosion cold and hot compress physical therapy bag heated in microwave oven | |
JP3150559U (en) | Cold Announcement Tool | |
JP3210986B2 (en) | Heat storage cool pack and heat storage cool pack | |
CN205198237U (en) | Gauze mask formula device of external application nasal part | |
JP2795782B2 (en) | Icing material | |
KR910004824B1 (en) | Hydrogel Production Method | |
JP2006043314A (en) | Thick sheet type treatment tool | |
JPH0316175B2 (en) | ||
JPH034248B2 (en) | ||
JPS59115378A (en) | Manufacturing method for head cooling gel to prevent hair loss due to side effects of anticancer drugs | |
CN203506963U (en) | Medical head cooling ice cap | |
CN207768597U (en) | A kind of ice pack | |
JPS58195558A (en) | Head cooling gel for preventing depilation due to side effect of anti-cancer agent | |
JPS5841943Y2 (en) | Simple water pillow or ice pack |